What's in HTA Co., Ltd.'s pipeline?

HTA Co., Ltd. has 5 drugs in our index: 0 marketed, 0 filed, 4 in Phase 3, 0 in Phase 2, 1 in Phase 1.

Which companies overlap with HTA Co., Ltd.'s portfolio?

Top competitors by shared drug class: Weill Medical College of Cornell University, Blue Earth Diagnostics, Hackensack Meridian Health, FutureChem, Genzyme, a Sanofi Company.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/hta-co-ltd.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-14 · How we verify

HTA Co., Ltd. — Portfolio Competitive Intelligence Brief

HTA Co., Ltd. pipeline: 0 marketed, 0 filed, 4 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

0 marketed 0 filed 4 Phase 3 0 Phase 2 1 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area
Florastamin[18F] Injection	Florastamin[18F] Injection	phase 3	PET imaging agent / radiopharmaceutical		Diagnostic Imaging / Infectious Disease
[18F]Florastamin Injection	[18F]Florastamin Injection	phase 3	statin	HMG-CoA reductase	Cardiovascular
Technetium[99mTc] Methylenediphosphonate Injection	Technetium[99mTc] Methylenediphosphonate Injection	phase 3	Radiopharmaceutical bone imaging agent	Bone hydroxyapatite mineral	Nuclear Medicine / Diagnostic Imaging
Sodium Fluoride F-18 Injection	Sodium Fluoride F-18 Injection	phase 3	Radiopharmaceutical		Oncology

Therapeutic area mix

Cardiovascular · 1
Diagnostic Imaging / Infectious Disease · 1
Nuclear Medicine / Diagnostic Imaging · 1
Oncology · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Weill Medical College of Cornell University · 2 shared drug classes
Blue Earth Diagnostics · 1 shared drug class
Hackensack Meridian Health · 1 shared drug class
FutureChem · 1 shared drug class
Genzyme, a Sanofi Company · 1 shared drug class
Gustave Roussy, Cancer Campus, Grand Paris · 1 shared drug class
Brigham and Women's Hospital · 1 shared drug class
Assistance Publique - Hôpitaux de Paris · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for HTA Co., Ltd.:

Cite this brief

Drug Landscape (2026). HTA Co., Ltd. — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/hta-co-ltd. Accessed 2026-05-14.